India’s pharmaceutical manufacturing sector continues to strengthen its production capabilities with Kwality Pharmaceuticals Limited acquiring 4 acres of land adjacent to its existing manufacturing facility in Amritsar.
The company plans to develop a fully automated pharmaceutical manufacturing facility designed to support future growth and meet evolving market demand.
🔹 Key Project Highlights:
📍 Location: Amritsar, Punjab
🏭 Land Acquired: 4 Acres
💉 Injectable Manufacturing: 4 production lines
💊 Other Formulations: 6+ lines for tablets, capsules, ophthalmic products and other oral solid dosage formulations
🌐 Quality Standards: Designed with applicable EU GMP requirements in consideration
📅 Target Completion: Q4 FY 2027–28
🚀 Expected Full Operations: Q2 FY 2028–29
Why This Development Matters
✅ Expansion of India’s pharmaceutical manufacturing infrastructure
✅ Increased production capabilities for existing and future product launches
✅ Greater adoption of automation and advanced manufacturing systems
✅ Strengthening of Amritsar as a pharmaceutical manufacturing destination
This development highlights the growing importance of industrial land acquisition, modern manufacturing infrastructure and technology-driven production in India’s pharmaceutical sector.
As India continues to emerge as a global pharmaceutical manufacturing hub, such investments create new opportunities across industrial infrastructure, plant development and manufacturing expansion.
#KwalityPharmaceuticals #PharmaceuticalIndustry #Manufacturing #IndustrialInvestment #IndustrialLand #Amritsar #Punjab #PharmaManufacturing #Automation #MakeInIndia #IndustrialDevelopment
